Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma

Clinical trial NCT04156828 · TERMINATED

Trial details

NCT number: NCT04156828
Sponsor: University of Washington
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Grade 3b Follicular Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Refractory Diffuse Large B-Cell Lymphoma Non-Hodgkin's Lymphoma

Start date: 2020-03-31
Primary completion: 2022-04-27
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.